Clinical Guidelines > Rapid Guidance

Rapid Guidance


Feedback on Rapid Guidance

Rapid guidance has not been through the usual rigorous BHIVA guidelines development process and has not been open to public consultation. We welcome feedback on the guidance for virtual consultations and the interim adult antiretroviral guidance (the interim statement on two-drug regimens was presented at BHIVA in 2019 and is only valid until publication of the updated BHIVA antiretroviral treatment guidelines). Please leave feedback via the form below.